Botulinum toxin type A therapy during pregnancy
Identifieur interne : 002024 ( PascalFrancis/Corpus ); précédent : 002023; suivant : 002025Botulinum toxin type A therapy during pregnancy
Auteurs : William J. Newman ; Thomas L. Davis ; Bismal B. Padaliya ; Cassondra D. Covington ; Chandler E. Gill ; Anna I. Ahramovitch ; P. David CharlesSource :
- Movement disorders [ 0885-3185 ] ; 2004.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
Injection with botulinum toxin type A (Botox) is a safe and efficacious treatment for idiopathic cervical dystonia. We present the first case report of clinical Botox treatment during pregnancy. This patient underwent four apparently uncomplicated full-term pregnancies while receiving regular Botox treatments.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
pA |
|
---|
Format Inist (serveur)
NO : | PASCAL 05-0001177 INIST |
---|---|
ET : | Botulinum toxin type A therapy during pregnancy |
AU : | NEWMAN (William J.); DAVIS (Thomas L.); PADALIYA (Bismal B.); COVINGTON (Cassondra D.); GILL (Chandler E.); AHRAMOVITCH (Anna I.); CHARLES (P. David) |
AF : | School of Medicine, Vanderbilt University Medical Center/Nashville, Tennessee/Etats-Unis (1 aut., 3 aut., 6 aut.); Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center/Nashville, Tennessee/Etats-Unis (2 aut., 4 aut., 5 aut., 7 aut.) |
DT : | Publication en série; Niveau analytique |
SO : | Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2004; Vol. 19; No. 11; Pp. 1384-1385; Bibl. 7 ref. |
LA : | Anglais |
EA : | Injection with botulinum toxin type A (Botox) is a safe and efficacious treatment for idiopathic cervical dystonia. We present the first case report of clinical Botox treatment during pregnancy. This patient underwent four apparently uncomplicated full-term pregnancies while receiving regular Botox treatments. |
CC : | 002B17; 002B02C; 002B02Q |
FD : | Système nerveux pathologie; Bontoxilysin; Traitement; Gestation |
FG : | Metalloendopeptidases; Peptidases; Hydrolases; Enzyme |
ED : | Nervous system diseases; Bontoxilysin; Treatment; Pregnancy |
EG : | Metalloendopeptidases; Peptidases; Hydrolases; Enzyme |
SD : | Sistema nervioso patología; Bontoxilysin; Tratamiento; Gestación |
LO : | INIST-20953.354000122631260240 |
ID : | 05-0001177 |
Links to Exploration step
Pascal:05-0001177Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Botulinum toxin type A therapy during pregnancy</title>
<author><name sortKey="Newman, William J" sort="Newman, William J" uniqKey="Newman W" first="William J." last="Newman">William J. Newman</name>
<affiliation><inist:fA14 i1="01"><s1>School of Medicine, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Davis, Thomas L" sort="Davis, Thomas L" uniqKey="Davis T" first="Thomas L." last="Davis">Thomas L. Davis</name>
<affiliation><inist:fA14 i1="02"><s1>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Padaliya, Bismal B" sort="Padaliya, Bismal B" uniqKey="Padaliya B" first="Bismal B." last="Padaliya">Bismal B. Padaliya</name>
<affiliation><inist:fA14 i1="01"><s1>School of Medicine, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Covington, Cassondra D" sort="Covington, Cassondra D" uniqKey="Covington C" first="Cassondra D." last="Covington">Cassondra D. Covington</name>
<affiliation><inist:fA14 i1="02"><s1>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Gill, Chandler E" sort="Gill, Chandler E" uniqKey="Gill C" first="Chandler E." last="Gill">Chandler E. Gill</name>
<affiliation><inist:fA14 i1="02"><s1>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ahramovitch, Anna I" sort="Ahramovitch, Anna I" uniqKey="Ahramovitch A" first="Anna I." last="Ahramovitch">Anna I. Ahramovitch</name>
<affiliation><inist:fA14 i1="01"><s1>School of Medicine, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Charles, P David" sort="Charles, P David" uniqKey="Charles P" first="P. David" last="Charles">P. David Charles</name>
<affiliation><inist:fA14 i1="02"><s1>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">05-0001177</idno>
<date when="2004">2004</date>
<idno type="stanalyst">PASCAL 05-0001177 INIST</idno>
<idno type="RBID">Pascal:05-0001177</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002024</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Botulinum toxin type A therapy during pregnancy</title>
<author><name sortKey="Newman, William J" sort="Newman, William J" uniqKey="Newman W" first="William J." last="Newman">William J. Newman</name>
<affiliation><inist:fA14 i1="01"><s1>School of Medicine, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Davis, Thomas L" sort="Davis, Thomas L" uniqKey="Davis T" first="Thomas L." last="Davis">Thomas L. Davis</name>
<affiliation><inist:fA14 i1="02"><s1>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Padaliya, Bismal B" sort="Padaliya, Bismal B" uniqKey="Padaliya B" first="Bismal B." last="Padaliya">Bismal B. Padaliya</name>
<affiliation><inist:fA14 i1="01"><s1>School of Medicine, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Covington, Cassondra D" sort="Covington, Cassondra D" uniqKey="Covington C" first="Cassondra D." last="Covington">Cassondra D. Covington</name>
<affiliation><inist:fA14 i1="02"><s1>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Gill, Chandler E" sort="Gill, Chandler E" uniqKey="Gill C" first="Chandler E." last="Gill">Chandler E. Gill</name>
<affiliation><inist:fA14 i1="02"><s1>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ahramovitch, Anna I" sort="Ahramovitch, Anna I" uniqKey="Ahramovitch A" first="Anna I." last="Ahramovitch">Anna I. Ahramovitch</name>
<affiliation><inist:fA14 i1="01"><s1>School of Medicine, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Charles, P David" sort="Charles, P David" uniqKey="Charles P" first="P. David" last="Charles">P. David Charles</name>
<affiliation><inist:fA14 i1="02"><s1>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2004">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Bontoxilysin</term>
<term>Nervous system diseases</term>
<term>Pregnancy</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Système nerveux pathologie</term>
<term>Bontoxilysin</term>
<term>Traitement</term>
<term>Gestation</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Injection with botulinum toxin type A (Botox) is a safe and efficacious treatment for idiopathic cervical dystonia. We present the first case report of clinical Botox treatment during pregnancy. This patient underwent four apparently uncomplicated full-term pregnancies while receiving regular Botox treatments.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>19</s2>
</fA05>
<fA06><s2>11</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Botulinum toxin type A therapy during pregnancy</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>NEWMAN (William J.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>DAVIS (Thomas L.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>PADALIYA (Bismal B.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>COVINGTON (Cassondra D.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>GILL (Chandler E.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>AHRAMOVITCH (Anna I.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>CHARLES (P. David)</s1>
</fA11>
<fA14 i1="01"><s1>School of Medicine, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA20><s1>1384-1385</s1>
</fA20>
<fA21><s1>2004</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000122631260240</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2005 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>7 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>05-0001177</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Injection with botulinum toxin type A (Botox) is a safe and efficacious treatment for idiopathic cervical dystonia. We present the first case report of clinical Botox treatment during pregnancy. This patient underwent four apparently uncomplicated full-term pregnancies while receiving regular Botox treatments.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B02C</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002B02Q</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Bontoxilysin</s0>
<s2>FE</s2>
<s2>FR</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Bontoxilysin</s0>
<s2>FE</s2>
<s2>FR</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Bontoxilysin</s0>
<s2>FE</s2>
<s2>FR</s2>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Traitement</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Treatment</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Gestation</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Pregnancy</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Gestación</s0>
<s5>05</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Metalloendopeptidases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Metalloendopeptidases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Metalloendopeptidases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Peptidases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Peptidases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Peptidases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Hydrolases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Hydrolases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Hydrolases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Enzyme</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Enzyme</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Enzima</s0>
<s2>FE</s2>
</fC07>
<fN21><s1>004</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 05-0001177 INIST</NO>
<ET>Botulinum toxin type A therapy during pregnancy</ET>
<AU>NEWMAN (William J.); DAVIS (Thomas L.); PADALIYA (Bismal B.); COVINGTON (Cassondra D.); GILL (Chandler E.); AHRAMOVITCH (Anna I.); CHARLES (P. David)</AU>
<AF>School of Medicine, Vanderbilt University Medical Center/Nashville, Tennessee/Etats-Unis (1 aut., 3 aut., 6 aut.); Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center/Nashville, Tennessee/Etats-Unis (2 aut., 4 aut., 5 aut., 7 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2004; Vol. 19; No. 11; Pp. 1384-1385; Bibl. 7 ref.</SO>
<LA>Anglais</LA>
<EA>Injection with botulinum toxin type A (Botox) is a safe and efficacious treatment for idiopathic cervical dystonia. We present the first case report of clinical Botox treatment during pregnancy. This patient underwent four apparently uncomplicated full-term pregnancies while receiving regular Botox treatments.</EA>
<CC>002B17; 002B02C; 002B02Q</CC>
<FD>Système nerveux pathologie; Bontoxilysin; Traitement; Gestation</FD>
<FG>Metalloendopeptidases; Peptidases; Hydrolases; Enzyme</FG>
<ED>Nervous system diseases; Bontoxilysin; Treatment; Pregnancy</ED>
<EG>Metalloendopeptidases; Peptidases; Hydrolases; Enzyme</EG>
<SD>Sistema nervioso patología; Bontoxilysin; Tratamiento; Gestación</SD>
<LO>INIST-20953.354000122631260240</LO>
<ID>05-0001177</ID>
</server>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002024 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 002024 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PascalFrancis |étape= Corpus |type= RBID |clé= Pascal:05-0001177 |texte= Botulinum toxin type A therapy during pregnancy }}
This area was generated with Dilib version V0.6.23. |